Early reports indicated that IL-18 was upregulated in patients with IBD, leading to upregulated levels of pro-inflammatory cytokines such as TNF-α, IL-1, and IL-6 [38,55]. This evidence concerns the gene IL1B and inflammatory bowel disease.